References: |
JH-II-127 is a highly potent, selective, and brain penetrant LRRK2 inhibitor,of both wild-type and G2019S mutant LRRK2.JH-II-127 substantially inhibits Ser910 and Ser935 phosphorylation of both wild-type LRRK2 and G2019S mutant at a concentration of 0.1-0.3 μM in a variety of cell types and is capable of inhibiting Ser935 phosphorylation in mouse brain following oral delivery of doses as low as 30 mg/kg. For the detailed information of JH-II-127, the solubility of JH-II-127 in water, the solubility of JH-II-127 in DMSO, the solubility of JH-II-127 in PBS buffer, the animal experiment (test) of JH-II-127, the cell expriment (test) of JH-II-127, the in vivo, in vitro and clinical trial test of JH-II-127, the EC50, IC50,and affinity,of JH-II-127, For the detailed information of JH-II-127, the solubility of JH-II-127 in water, the solubility of JH-II-127 in DMSO, the solubility of JH-II-127 in PBS buffer, the animal experiment (test) of JH-II-127, the cell expriment (test) of JH-II-127, the in vivo, in vitro and clinical trial test of JH-II-127, the EC50, IC50,and affinity,of JH-II-127, Please contact DC Chemicals. |